Abstract
Chronic lymphocytic leukemia (CLL) is a phenotypically distinguishable form of B-lymphoid leukemias. The regularity of surface membrane antigen expression patterns, their interrelationships as well as the effects of the three frequent chromosomal aberrations, ie 11q deletion, 13q deletion and trisomy 12, were investigated in 35 classic CLL cases by flow cytometry. The two-way cluster analysis of 31 individual antigens revealed three expression patterns: (1) most cells in most cases positive (CD5, CD19, CD20, CD23, CD27, CD40, CD45, CD45RA); (2) most cells in most cases negative (CD10, CD14, CD34, CD122, CD154, mIgG); and (3) a mixed pattern with a variable number of positive cases and a variable percentage of positive cells in individual cases (CD11c, CD21, CD22, CD25, CD38, CD45RO, CD79b, CD80, CD95, CD124, CD126, CD130, FMC7, mIgD, mIgκ, mIgλ, mIgM). The expressions of several antigens were strongly interdependent, even when antigens belonged to entirely different gene families. Such antigen pairs were: CD11c/CD21; CD19/CD45; CD19/CD79b; CD22/CD45RA; CD23/Igκ; CD25/mIgM; CD27/CD45; CD45/CD79b; CD45RA/Igκ. In contrast, the expression of some antigens was mutually exclusive, the best examples being CD45RA/CD45RO, CD38/CD80 and CD45RA/CD80. Deletion of chromosome arm 11q attenuated expression of splicing variant CD45RA, but enhanced CD45RO expression. In contrast, cases of trisomy 12 were associated with enhanced CD45RA and attenuated CD45RO expression. Similarly, trisomy 12 was associated with enhanced CD27 and mIgκ expression. The variable levels of signaling surface membrane antigens, their interactions and interference by genetic aberrations are likely to affect the clinical progression and drug response of CLL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kipps T . Chronic lymphocytic leukemia Curr Opion Hematol 2000 7: 223–232
Meinhardt G, Wendtner C, Hallek M . Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival J Mol Med 1999 77: 282–293
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P . Genomic aberrations and survival in chronic lymphocytic leukemia N Engl J Med 2000 343: 1910–1916
Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C . Proposals for the classification of chronic (mature) B and T lymphoid leukaemias J Clin Pathol 1989 42: 567–584
Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D . The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL Leukemia 1994 8: 1640–1645
Rozman C, Montserrat E, Rodriguez-Fernandez J et al. Bone marrow histologic pattern – the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases Blood 1984 64: 642–648
Dohner H, Stilgenbauer S, Döhner K, Bentz M, Lichter P . Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analyses J Mol Med 1999 77: 266–281
Zupo S, Isnardi L, Megna M, Massara R, Malavasi F, Dono M, Cosulich E, Ferrarini M . CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis Blood 1996 88: 1365–1374
Lopez-Matas M, Rodriguez-Justo M, Morilla R, Catovsky D, Matutes E . Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia Haematologica 2000 85: 1140–1145
Matutes E, Catovsky D . The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B cell disorders Leuk Lymphoma 1994 13: 11–14
Vilpo J, Vilpo L, Hulkkonen J, Lankinen M, Kuusela P, Hurme M . Non-specific binding compromises the purification yields of leukemic B cells in chronic lymphocytic leukemia: prevention by collagen coating Eur J Haematol 1998 60: 65–67
Vilpo J, Koski T, Vilpo L . Selective toxicity of vincristine against chronic lymphocytic leukemia cells in vitro Eur J Haematol 2000 65: 1–9
Eisen MB, Spellman PT, Brown PO, Botstein D . Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci USA 1998 95: 14863–14868
Zupo S, Massara R, Dono M, Rossi E, Malavasi F, Cosulich M, Ferrarini M . Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells by cross-linking of surface IgM or IgD Blood 2000 95: 1199–1206
Damle RN, Wasil T, Fais F et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 1999 94: 1840–1847
Yu Y, Rabinowitz R, Polliac A, Ben-Bassat H, Schlesinger M . B-lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule Eur J Haematol 2000 64: 376–384
Ranheim EA, Cantwell MJ, Kipps TJ . Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells Blood 1995 85: 3556–3565
van Oers MH, Pals ST, Evers LM, van der Schoot CE, Koopman G, Bonfrer JM, Hintzen RQ, von dem Borne AE, van Lier RA . Expression and release of CD27 in human B-cell malignancies Blood 1993 82: 3430–3436
Sembries S, Pahl H, Stilgenbauer S, Döhner H, Schriever F . Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion Blood 1999 93: 624–631
van den Hove LE, van Gool SW, Vandenberghe P, Bakkus M, Thielemans K, Boogaerts MA, Ceuppens JL . CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules Leukemia 1997 11: 572–580
Tsukada N, Aoki S, Maruyama S, Kishi K, Takahashi M, Aizawa Y . The heterogenous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon J Exp Clin Cancer Res 1997 16: 171–176
Schattner EJ, Mascarenhas J, Reyfman I, Koshy M, Woo C, Friedman SM, Crow MK . Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity Blood 1998 91: 2689–2697
McKay C, Hewitt E, Ozanne B, Cushley W . A functional role for interleukin (IL-)4-driven cyclic AMP accumulation in human B lymphocytes Cytokine 2000 12: 731
Fluckiger AC, Briere F, Zurawski G, Bridon JM, Banchereau J . IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells Immunology 1994 83: 397–403
Iwasaki T, Hamano T, Fujimoto J, Kakishita E . Regulation of interleukin-6 and interleukin-6R alpha (gp80) expression by murine immunoglobulin-secreting B cell hybridomas Immunology 1998 93: 498–504
Yancopoulos G, Alt F . Regulation of the assembly and expression of variable-region genes Ann Rev Immunol 1986 4: 339–348
Zola H, Melo J, Zowtyj H, Nikoloutsopoulos A, Skinner J . The leukocyte-common antigen (CD45) complex and B-lymphocyte activation Hum Immunol 1990 27: 368–377
Maddy AH, Sanderson A, Mackie MJ, Smith SK . The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukaemia Immunology 1989 68: 346–352
Agematsu K, Nagumo H, Yang F et al. B cell subpopulation separated by CD27 and crucial collaborations of CD27+ B cells and helper T cells in immunoglobulin production Eur J Immunol 1997 27: 2073–2079
Klein U, Rajewsky K, Kuppers R . Human immunoglobulin (Ig)M+IgD+ peripheral blood cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells J Exptl Med 1998 188: 1679–1689
Tangye SG, Weston KM, Raison RL . Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B cells Leuk Lymphoma 1998 31: 121–130
Goldsby R, Kindt T, Osborne B . Kuby Immunology (4th edn) WH Freeman: New York 2000
Karhu R, Knuutila S, Kallioniemi OP, Siitonen S, Aine R, Vilpo L, Vilpo J . Frequent loss of the 11q14–24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Tampere CLL Group Gene Chrosome Cancer 1997 19: 286–290
Larramendy M, Siitonen S, Zhu Y, Hurme M, Vilpo L, Vilpo J, Knuutila S . Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis Cytogenet Cell Genet 1998 82: 215–221
Zhu Y, Monni O, El-Rifai W, Siitonen S, Vilpo L, Vilpo J, Knuutila S . Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia Leukemia 1999 13: 708–712
Lens D, Matutes E, Catovsky D, Coignet LJ . Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL) Leukemia 2000 14: 427–430
Aalto Y, El-Rifai W, Vilpo L, Ollila J, Nagy B, Vihinen M, Vilpo J, Knuutila S . Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion Leukemia 2001 15: 1721–1728
Garcia Vela J, Delgado I, Benito L, Monteserin M, Garcia Alonso L, Somolinos N, Andreu M, Ona F . CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection Leukemia 1999 13: 1501–1505
Alfarano A, Indraccolo S, Circosta P et al. An alternatively spliced form of CD79b gene may account for altered B cell receptor expression in B-chronic lymphocytic leukemia Blood 1999 93: 2327–2335
Koski T, Karhu R, Visakorpi T, Vilpo L, Knuutila S, Vilpo J . Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance Eur J Haematol 2000 65: 32–39
Acknowledgements
This work was supported by grants from the Medical Research Fund of Tampere University Hospital and the Finnish Foundation for Cancer Research. We thank Leena Pankko and Merja Suoranta for their skilful technical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hulkkonen, J., Vilpo, L., Hurme, M. et al. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities. Leukemia 16, 178–185 (2002). https://doi.org/10.1038/sj.leu.2402363
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402363
Keywords
This article is cited by
-
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Current Hematologic Malignancy Reports (2016)
-
Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias
Leukemia (2003)
-
Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B
Leukemia (2003)